Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New anticonvulsant series developed from SB-204269 at SKB

Sep. 10, 1998

Dopamine D3 antagonist with improved selectivity, clearance discovered at SB

Sep. 10, 1998

Dutch academics identify free radical scavengers/xanthine oxidase inhibitors

Sep. 10, 1998

New advances in antiobesity drug therapy reported by Novartis

Sep. 10, 1998

Potent and selective inhibitors of p56lck kinase developed at Celltech

Sep. 9, 1998

Astra presents data on novel series of cPLA2 inhibitors

Sep. 9, 1998

Radioiodinated phospholipid ether analogues useful for tumor imaging

Sep. 9, 1998

Novel WHI compound inhibits 5-LO translocation in mast cells

Sep. 9, 1998

Glaxo Wellcome describes hypoglycemic activity of PPAR ligand

Sep. 9, 1998

Novel ACAT inhibitors from DuPont Pharmaceuticals debut at ACS meeting

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...